Rahko applies quantum machine learning algorithms to drug discovery and pharmaceutical research, developing quantum-enhanced computational methods for molecular analysis, drug-target interactions, and compound optimization that leverage quantum computing’s potential advantages in exploring complex chemical space for therapeutic applications.
Nathan Brown (Co-founder, CEO), Leo Canas (Co-founder, CTO)
Explore other quantum computing companies in similar categories or regions.